Please login to the form below
BPDCN
This page shows the latest BPDCN news and features for those working in and with pharma, biotech and healthcare.
Orphan drugs dominate FDA's record-breaking year
The last few days of the year also saw approvals for Stemline Therapeutics’ Elzonris (tagraxofusp) – the first drug to be licensed for rare cancer blastic plasmacytoid dendritic cell neoplasm (BPDCN) – and
Latest news
-
Cellectis floored by patient death in CAR-T trial
The 78-year-old man with blastic plasmacytoid dendritic cell neoplasm (BPDCN) started the treatment with Cellectis' UCART123 candidate at the MD Anderson Cancer Centre in the US in mid-August ... Shares in Cellectis went into a nosedive on news of the
-
Cellectis gets FDA nod for 'off-the-shelf' CAR-T trial
UCART123 is a gene-edited CAR-T cell therapy that targets CD123 and will be tested in acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN).
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Featured jobs
- Head of Partnerships - Competitive - London
-
Competitive Salary Offered
-
Senior Medical Writer
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Midweight Brand Planner
-
Up to £50, 000
Subscribe to our email news alerts
- Stung by critics, J&J says antidepressant Spravato saves money
- Still no breakthrough on Orkambi talks, MPs want answers
- Curiosity – did it ever really kill the cat?
- Amgen buys Danish partner Nuevolution for $167m
- 90TEN named Best Agency in Continental Europe at PRWeek Global Awards
- Latecomer Lilly preps its IL-23 drug for Crohn’s disease
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...
Latest intelligence
- The Exhibition Hall: Past, Present and Future
- As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
- Success breeds success
- This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
- Turning learning into action: The challenge of behaviour change
- ...
Quick links
Infographics
